Related Experiment Videos

Campylobacter enteritis in children: clinical and laboratory findings in 137 cases

S D Puthucheary1, N Parasakthi, S T Liew

  • 1Department of Medical Microbiology, University Hospital, Faculty of Medicine, University of Malaya, Kuala Lumpur.

Insights

Campylobacter jejuni is the main cause of diarrhea in children under five, particularly infants aged 2-12 months. Erythromycin is effective against most strains, with 96.2% sensitivity observed.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Microbiology

Background:

  • Campylobacter infections are a significant cause of childhood diarrhea.
  • Campylobacter jejuni is a predominant enteropathogen in pediatric populations.

Purpose of the Study:

  • To characterize the clinical features and microbiological aspects of Campylobacter diarrhea in children.
  • To evaluate the antibiotic susceptibility of Campylobacter strains, focusing on erythromycin.

Main Methods:

  • Retrospective review of 137 children diagnosed with Campylobacter diarrhea.
  • Identification of bacterial enteropathogens and assessment of clinical symptoms.
  • Antimicrobial susceptibility testing, including Minimum Inhibitory Concentration (MIC) for erythromycin.

Main Results:

  • Campylobacter jejuni was the predominant species identified.
  • Most affected children were under 5 years old, with a peak incidence in infants aged 2-12 months.
  • Fever and bloody diarrhea were common; erythromycin showed high sensitivity (96.2%) with an MIC90 of 2 mg/l.

Conclusions:

  • Campylobacter jejuni is a major cause of diarrhea in young children, presenting with significant gastrointestinal symptoms.
  • Erythromycin is a potentially effective treatment option for Campylobacter infections in this age group, demonstrating high in vitro sensitivity.

Related Concept Videos